Archive · 17 Dec 2025
LMIL-Renalyx Wins Licence for AI-Based Hemodialysis Machines
Lords Mark Industries Ltd.
(LMIL) and Renalyx have received a special licence from the Indian government to make smart dialysis machines that use AI.
These machines are very advanced and can help people with kidney problems.
The company also got a CE certification, which means their machines meet high safety and quality standards in Europe.
This is a big deal because only a few companies worldwide have this certification.
The machines use AI to make dialysis treatments safer and more precise.
India has a lot of people who need dialysis, and this new technology can help meet that need.
The company plans to keep improving and making more advanced healthcare technologies.
LMIL-Renalyx received a licence to manufacture Class C AI-Based Smart Hemodialysis Machines from CDSCO.
The company earned the globally recognized CE certification for its dialysis systems.
Class C devices are high-risk, life-sustaining medical equipment requiring compliance with 140+ quality and safety parameters.
India's dialysis market is valued at USD 5 billion in 2024, serving 18–20 lakh CKD patients with growing demand.
LMIL-Renalyx's AI-driven machines integrate automation, predictive safety alerts, and real-time analytics to reduce human error.
- Who
- Lords Mark Industries Ltd. (LMIL) - Renalyx
- What
- Received licence for Class C AI-Based Smart Hemodialysis Machines and CE certification
- When
- Not specified
- Where
- India
- Why
- To strengthen India's self-reliance in healthcare technology and reduce dependence on imported machines
- Company
- Lords Mark Industries Ltd. (LMIL) - Renalyx
- Licence
- Class C AI-Based Smart Hemodialysis Machines
- Certification
- CE Marking
- Regulatory Body
- Central Drugs Standard Control Organisation (CDSCO)
- Market Value
- USD 5 billion (2024)
- CKD Patients
- 18–20 lakh
- New ESRD Cases Annually
- 2.2–2.5 lakh
- Dialysis Centres in India
- Fewer than 6,000